News
Vertex: Shorter therapy with hep C drug is OK
August 10, 2010 10:37 am | by Mass High Tech: The Journal of New England Technology | CommentsVertex Pharmaceuticals Inc. has announced that a late-stage clinical trial has found that doubling the length of therapy for its hepatitis C drug candidate does not substantially increase the benefit.
Another buyout adds to iMedx med transcription leadership
August 10, 2010 10:36 am | by Mass High Tech: The Journal of New England Technology | CommentsMedical transcription firm iMedX Inc., of Shelton, Conn., has announced its acquisition of Louisiana-based MedTech Transcriptions Inc. The buyout is the fifth acquisition iMedX has completed in 12 months.
Study Shows Physicians Reluctant to Use Chemoprevention for Prostate Cancer -
August 10, 2010 10:33 am | by AACR | Comments• Use of finasteride for prostate cancer prevention has not increased. • Experts expect a slow adoption of chemoprevention strategies. PHILADELPHIA - Despite the dramatic results of the Prostate Cancer Prevention Trial (PCPT), which showed a significant reduction in prostate cancer among...
New Findings Further Clarify Breast Cancer Risk With Hormone Therapy
August 10, 2010 10:33 am | by AACR | Comments• Risk varied according to BMI, with greater risks for thinner women. • Longer duration of hormone therapy increased breast cancer risk. PHILADELPHIA - A new analysis of the California Teachers Study, which analyzed hormone replacement therapy use among 2,857 women for almost 10 years,...
Miller joins Concert Pharma's corporate leadership team
August 10, 2010 9:38 am | by Mass High Tech: The Journal of New England Technology | CommentsLexington-based Concert Pharmaceuticals Inc. has named Gregory Miller, a former senior director of business development and corporate strategy at AMAG Pharmaceuticals Inc., as its head of business and corporate development.
Teleflex closes $400M sale of senior notes
August 10, 2010 8:45 am | by The Associated Press | CommentsTeleflex Inc. said Tuesday it sold $400 million in senior notes, and used the proceeds to prepay debt and fund convertible bond hedge bond transactions.Teleflex's new senior notes are due in 2017. The total includes $50 million in notes purchased by the underwriters of its offering. The company...
NIH EUREKA Award Will Enable Design of New Brain Tumor Treatment
August 10, 2010 8:36 am | by Georgia Tech Institute of Technology | CommentsThe Georgia Institute of Technology has received a EUREKA grant from the National Cancer Institute to design a new way to treat invasive brain tumors by capturing the migrating cells that spread the disease.
NeuroMetrix 2Q loss widens as revenue sinks
August 10, 2010 7:45 am | by The Associated Press | CommentsMedical device maker NeuroMetrix Inc. said Tuesday its second-quarter loss deepened, as a change in Medicare reimbursement hurt revenue, which fell more than 40 percent.The Waltham, Mass., company said it lost $4.5 million, or 20 cents per share, in the three months that ended June 30. That...
Penwest to be bought by Endo Pharmaceuticals
August 10, 2010 7:37 am | by Mass High Tech: The Journal of New England Technology | CommentsPenwest Pharmaceuticals Co. has agreed to be acquired by 13-year partner Endo Pharmaceuticals Holdings Co. for about $144 million. Penwest develops extended-release drug delivery technology used in Opana ER, a pain killer launched and commercialized by Endo.
Solar Energy Initiatives, Inc. Appoints Mr. Jack Zwick to Its Board of Directors
August 10, 2010 6:45 am | by The Associated Press | Commentshttp://www.solarenergyinitiatives.com () —Solar Energy Initiatives, Inc. (OTCBB: SNRY), with businesses in solar project development, distribution and workforce training, today announced the appointment of Mr. Jack Zwick, CPA to its Board of Directors. The appointment comes at a vital time...
Exogenesis bumps financing up to $4.5M
August 10, 2010 6:37 am | by Mass High Tech: The Journal of New England Technology | CommentsExogenesis Corp., a gas cluster ion beam technology firm in Billerica, has raised $4.5 million in an amended equity offering. The company uses the GCIB technology to process implantable medical devices.
Neurochip technology developed by Canadian team
August 10, 2010 6:35 am | by EurekAlert | Comments(University of Calgary) The University of Calgary, Faculty of Medicine scientists who proved it is possible to cultivate a network of brain cells that reconnect on a silicon chip -- or the brain on a microchip -- have been involved in the development of new technology that monitors brain...
Regional protocols improve quality of care for aortic dissection patients
August 10, 2010 6:35 am | by EurekAlert | Comments(Minneapolis Heart Institute Foundation) Using a standardized protocol within a regional health network, a multidisciplinary acute aortic dissection program resulted in a 43 percent reduction in time to diagnosis for all AAD patients over the course of five years, based on study results...
Chairman and Chief Scientist at ERT Recognized as One of 100 Most Inspiring People in the Life Sciences Industry
August 10, 2010 6:35 am | by RealWire | CommentsPHILADELPHIA, PA 10 August 2010 - ERT, a leading provider of centralized services to global pharmaceutical, biotechnology and medical device companies, announces that Joel Morganroth, MD, Chairman and Chief Scientist, has been acknowledged by PharmaVOICE magazine as one of the 100 most...
Henry Schein will sell up to $400M in senior notes
August 10, 2010 5:45 am | by The Associated Press | CommentsHenry Schein Inc. will sell up to $400 million in senior notes to two insurers over the next three years, the medical device and services distributor said Tuesday.The company may issue the notes between now and August 2012. It will be able to set the terms of the notes, which can range from...
